Merrill Goozner

1.1k total citations
24 papers, 572 citations indexed

About

Merrill Goozner is a scholar working on Economics and Econometrics, Physiology and Reproductive Medicine. According to data from OpenAlex, Merrill Goozner has authored 24 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 5 papers in Physiology and 4 papers in Reproductive Medicine. Recurrent topics in Merrill Goozner's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Biomedical Ethics and Regulation (4 papers) and Economic and Financial Impacts of Cancer (4 papers). Merrill Goozner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Biomedical Ethics and Regulation (4 papers) and Economic and Financial Impacts of Cancer (4 papers). Merrill Goozner collaborates with scholars based in United States and Australia. Merrill Goozner's co-authors include Cara B. Ebbeling, David S. Ludwig, Lenard I. Lesser, David Wypij, G. Mudur, Melissa Sweet, Gary Schwitzer, David Henry, Amanda Wilson and Arthur L. Caplan and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, PLoS Medicine and Addiction.

In The Last Decade

Merrill Goozner

24 papers receiving 528 citations

Peers

Merrill Goozner
Gary Schwitzer United States
Judy Watkins United Kingdom
Marc A. Rodwin United States
Darren E. Ƶinner United States
Carol R. Horowitz United States
Alan Cassels Canada
Matthew Herder Canada
Sharona Hoffman United States
Stuart Hogarth United Kingdom
Chris Graf United States
Gary Schwitzer United States
Merrill Goozner
Citations per year, relative to Merrill Goozner Merrill Goozner (= 1×) peers Gary Schwitzer

Countries citing papers authored by Merrill Goozner

Since Specialization
Citations

This map shows the geographic impact of Merrill Goozner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merrill Goozner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrill Goozner more than expected).

Fields of papers citing papers by Merrill Goozner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merrill Goozner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merrill Goozner. The network helps show where Merrill Goozner may publish in the future.

Co-authorship network of co-authors of Merrill Goozner

This figure shows the co-authorship network connecting the top 25 collaborators of Merrill Goozner. A scholar is included among the top collaborators of Merrill Goozner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merrill Goozner. Merrill Goozner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goozner, Merrill. (2019). Health Care: The Causes and Consequences of Slower-Growing Costs. Challenge. 62(1). 67–76. 1 indexed citations
2.
Goozner, Merrill. (2016). Ascension seeks productivity elixir from its joint venture in Cayman Islands.. PubMed. 46(6). 12–5. 1 indexed citations
3.
Goozner, Merrill. (2013). Strategies to Reduce Cancer-Care Costs. JNCI Journal of the National Cancer Institute. 105(4). 247–248. 2 indexed citations
4.
Goozner, Merrill. (2012). Drug Approvals 2011: Focus on Companion Diagnostics. JNCI Journal of the National Cancer Institute. 104(2). 84–86. 16 indexed citations
5.
Goozner, Merrill. (2011). Accelerated Drug Approval: FDA May Get Tougher; Companies Cite Hurdles. JNCI Journal of the National Cancer Institute. 103(6). 455–457. 4 indexed citations
6.
Goozner, Merrill. (2011). Duke Scandal Highlights Need for Genomics Research Criteria. JNCI Journal of the National Cancer Institute. 103(12). 916–917. 11 indexed citations
7.
Goozner, Merrill. (2011). Avastin Hearing Leads to More Uncertainty Over Drug's Future. JNCI Journal of the National Cancer Institute. 103(15). 1148–1150. 10 indexed citations
8.
Goozner, Merrill. (2010). Big Databases: Outcomes Research Begins To Yield Results. JNCI Journal of the National Cancer Institute. 102(4). 215–217. 1 indexed citations
9.
Goozner, Merrill. (2010). Oncologists Want FDA To Rethink REMS. JNCI Journal of the National Cancer Institute. 102(23). 1748–1751. 3 indexed citations
10.
Goozner, Merrill. (2010). United Healthcare, Five Oncology Practices Try Bundled Payments. JNCI Journal of the National Cancer Institute. 103(1). 8–10. 4 indexed citations
11.
Goozner, Merrill. (2010). NIH Proposes New Conflict-of-Interest Rules for Investigators. JNCI Journal of the National Cancer Institute. 102(14). 1006–1007. 3 indexed citations
12.
Goozner, Merrill. (2010). FDA Increases Focus on Postmarketing Studies. JNCI Journal of the National Cancer Institute. 102(17). 1302–1304. 4 indexed citations
13.
Goozner, Merrill, et al.. (2009). A common standard for conflict of interest disclosure in addiction journals. Addiction. 104(11). 1779–1784. 27 indexed citations
14.
Lesser, Lenard I., Cara B. Ebbeling, Merrill Goozner, David Wypij, & David S. Ludwig. (2007). Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles. PLoS Medicine. 4(1). e5–e5. 240 indexed citations
15.
Goozner, Merrill. (2006). Innovation in Biomedicine: Can Stem Cell Research Lead the Way to Affordability?. PLoS Medicine. 3(5). e126–e126. 8 indexed citations
16.
Schwitzer, Gary, G. Mudur, David Henry, et al.. (2005). What Are the Roles and Responsibilities of the Media in Disseminating Health Information?. PLoS Medicine. 2(7). e215–e215. 119 indexed citations
17.
Schwitzer, Gary, G. Mudur, David Henry, et al.. (2005). Correction: What Are the Roles and Responsibilities of the Media in Disseminating Health Information?. PLoS Medicine. 2(8). e321–e321. 21 indexed citations
18.
Goozner, Merrill. (2004). From The $800 Million Pill - Me Too!. PubMed Central. 6(2). 1 indexed citations
19.
Goozner, Merrill. (2004). The $800 Million Pill. 56 indexed citations
20.
Goozner, Merrill. (2004). Unrevealed: Non-Disclosure of Conflicts of Interest In Four Leading Medical and Scientific Journals. DigitalGeorgetown (Georgetown University Library). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Schwitzer Breakdown of academic impact, for papers by Judy Watkins Breakdown of academic impact, for papers by Marc A. Rodwin Breakdown of academic impact, for papers by Darren E. Ƶinner Breakdown of academic impact, for papers by Carol R. Horowitz Breakdown of academic impact, for papers by Alan Cassels Breakdown of academic impact, for papers by Matthew Herder Breakdown of academic impact, for papers by Sharona Hoffman Breakdown of academic impact, for papers by Stuart Hogarth Breakdown of academic impact, for papers by Chris Graf
Rankless by CCL
2026